Teyssedou Lenaic Nathanael
Insider CIK 2123881 · ADXN PRINCIPAL ACCOUNTING OFFICER
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 90,529 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 90,529 | — | $0 | 512,379 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 65,620 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 65,620 | — | $0 | 537,288 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 30,000 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 30,000 | — | $0 | 572,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 37,770 | — | $0 | 565,138 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 10,000 | — | $0 | 592,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 59,530 | — | $0 | 543,378 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 59,530 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 208,974 | — | $0 | 393,934 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 208,974 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 100,485 | — | $0 | 502,423 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 100,485 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 37,770 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 10,000 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 100,485 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 100,485 | — | $0 | 502,423 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 208,974 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 208,974 | — | $0 | 393,934 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 90,529 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 90,529 | — | $0 | 512,379 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 65,620 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 65,620 | — | $0 | 537,288 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 30,000 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 30,000 | — | $0 | 572,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 10,000 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 10,000 | — | $0 | 592,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 59,530 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 59,530 | — | $0 | 543,378 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 37,770 | — | $0 | 602,908 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 37,770 | — | $0 | 565,138 | SEC↗ |